These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

85 related articles for article (PubMed ID: 3900811)

  • 21. Lack of effect of a new spasmolytic agent, rociverine, on intraocular pressure, pupil size and iridocorneal angle in patients with angle-closure glaucoma.
    Pardini M; Saponati G
    Pharmatherapeutica; 1983; 3(7):445-50. PubMed ID: 6669589
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Bicifadine: non-narcotic analgesic activity of 1-aryl-3-azabicyclo[3.1.0] hexanes.
    Epstein JW; Osterberg AC; Regan BA
    NIDA Res Monogr; 1982 Apr; 41():93-8. PubMed ID: 6811945
    [No Abstract]   [Full Text] [Related]  

  • 23. [The use of a new antispasmotic, rociverine, in the radiologic examination of the duodenum].
    De Miranda B; La Ragione M
    Farmaco Prat; 1981 Apr; 36(4):228-32. PubMed ID: 7227498
    [No Abstract]   [Full Text] [Related]  

  • 24. Effectlessness of a new spasmolytic (rociverine) on intraocular pressure, pupil size, and iridocorneal angle in ophthalmically healthy subjects.
    Pardini M; Saponati G
    Clin Ther; 1981; 4(1):48-55. PubMed ID: 7273068
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [1-ethoxysilatrane--an inhibitor of the development of experimental atherosclerotic lesion of the aorta].
    Konova NS; Pertsovskiĭ AI; Voronkov MG
    Dokl Akad Nauk SSSR; 1984; 276(3):757-9. PubMed ID: 6468268
    [No Abstract]   [Full Text] [Related]  

  • 26. Cystometric evaluation of the activity of a new spasmolytic agent - rociverine.
    Manganelli A
    Farmaco Prat; 1979 Sep; 34(9):384-92. PubMed ID: 553816
    [No Abstract]   [Full Text] [Related]  

  • 27. Rociverine compared with other spasmolytics for cardiovascular effects.
    Guelfi M; Schiantarelli P; Subissi A
    Farmaco Prat; 1981 Aug; 36(8):374-82. PubMed ID: 7274417
    [No Abstract]   [Full Text] [Related]  

  • 28. Mechanism of smooth muscle relaxation by rociverine.
    D'Agostino G; Zonta F; Santagostino Barbone MG; Grana E; Brunori P; Subissi A
    Arzneimittelforschung; 1984; 34(5):584-9. PubMed ID: 6540576
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Treatment of irritable colon syndrome with rociverine].
    Modena L
    Minerva Med; 1993 May; 84(5):263-8. PubMed ID: 8316345
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Investigation of rociverine + dipyrone for antispasmodic and analgesic interactions.
    Schiantarelli P; Murmann W; Magi S
    Arzneimittelforschung; 1979; 29(5):760-5. PubMed ID: 582975
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Effect of parenteral dezocine and placebo in cancer pain.
    Staquet M
    Curr Med Res Opin; 1980; 6(9):634-7. PubMed ID: 6996934
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Changes in the periodontium in prolonged hypodynamia and the use of biphosphanates and silatrane for the purpose of their prevention].
    Volozhin AI; Amel'kina GV
    Patol Fiziol Eksp Ter; 1989; (3):72-5. PubMed ID: 2797906
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Atranes: their ulcerostatic effect and its possible mechanisms].
    Kuznetsov IG; Rasulov MM; Voronkov MG
    Izv Akad Nauk SSSR Biol; 1990; (1):67-74. PubMed ID: 2348003
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Preliminary clinical experience with dezocine, a new potent analgesic.
    Oosterlinck W; Verbaeys A
    Curr Med Res Opin; 1980; 6(7):472-4. PubMed ID: 7363647
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Stomach diseases. Pathogenesis and therapeutic aspects with special regard to therapy with Sucsan-Azulen comp].
    Trentmann M
    Fortschr Med; 1974 Nov; 92(32):1325-8. PubMed ID: 4457439
    [No Abstract]   [Full Text] [Related]  

  • 36. [Acute effects of the angiotensin converting enzyme inhibitor ramipril in patients with coronary heart disease].
    Unterberg C; Buchwald A; Vogt A; Wiegand V
    Med Klin (Munich); 1990 Feb; 85(2):78-81. PubMed ID: 2138704
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Rociverine, a new antispasmodic agent with balanced neurotropic and myotropic activity.
    Toson G; Schiantarelli P; Murmann W
    Arzneimittelforschung; 1978; 28(7):1130-42. PubMed ID: 582702
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Ambulatory multicenter study of Triatec (ramipril). Observations concerning the lessons of the trial for the realization of future trials and for the management of hypertensive patients].
    Battaglia C; Gallet M; Carré A
    Rev Prat; 1990 Jun; 40(18 Suppl):45-7. PubMed ID: 2143598
    [No Abstract]   [Full Text] [Related]  

  • 39. Effects of rociverine and other spasmolytic agents on caerulein-induced delay in gastric emptying in the conscious rat.
    Subissi A; Guelfi M
    Arch Int Pharmacodyn Ther; 1982 May; 257(1):130-7. PubMed ID: 7114969
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [The synthesis and pharmacological activities of analogs of erycibe alkaloid II].
    He HM; Shen JX; Ma XY; He XP
    Yao Xue Xue Bao; 1989; 24(5):335-40. PubMed ID: 2609967
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.